Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine



   palmoplantar keratosis
  

Disease ID 1364
Disease palmoplantar keratosis
Definition
Group of mostly hereditary disorders characterized by thickening of the palms and soles as a result of excessive keratin formation leading to hypertrophy of the stratum corneum (hyperkeratosis).
Synonym
et keratoderma palmaris plantaris
hyperkeratosis of palms and soles
hyperkeratosis of the palms and soles
hyperkeratosis palmaris et plantaris
keratoderma palmaris et plantaris
keratoderma palmoplantar
keratoderma, palmoplantar
keratoderma, palmoplantar [disease/finding]
keratodermas, palmoplantar
keratoses, palmoplantar
keratosis palmaris et plantaris (disorder)
keratosis, palmoplantar
palmar and plantar keratoderma
palmoplantar hyperkeratosis
palmoplantar keratoderma
palmoplantar keratoderma (disorder)
palmoplantar keratodermas
palmoplantar keratoses
thick palms and soles
thickened palms and soles
DOID
UMLS
C0022596
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:20)
C0014859  |  esophageal cancer  |  2
C0878544  |  cardiomyopathy  |  2
C0010674  |  cystic fibrosis  |  2
C0031099  |  periodontitis  |  2
C0265334  |  pachyonychia congenita  |  2
C0031106  |  early-onset periodontitis  |  2
C0040259  |  tinea pedis  |  1
C0870082  |  hyperkeratosis  |  1
C0546837  |  oesophageal cancer  |  1
C0013338  |  growth hormone deficiency  |  1
C0155550  |  neural deafness  |  1
C0018784  |  sensorineural deafness  |  1
C0079153  |  epidermolytic hyperkeratosis  |  1
C0014527  |  epidermolysis bullosa  |  1
C0022584  |  tylosis  |  1
C0022593  |  keratosis  |  1
C0022595  |  keratosis follicularis  |  1
C0017574  |  gingivitis  |  1
C0036920  |  sezary syndrome  |  1
C0020757  |  ichthyosis  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:32)
3728  |  JUP  |  UniProtKB-KW
284654  |  RSPO1  |  UniProtKB-KW
831  |  CAST  |  UniProtKB-KW
3848  |  KRT1  |  UniProtKB-KW
3868  |  KRT16  |  UniProtKB-KW
362  |  AQP5  |  UniProtKB-KW
2706  |  GJB2  |  CTD_human;UniProtKB-KW
2697  |  GJA1  |  UniProtKB-KW
51371  |  POMP  |  UniProtKB-KW
1832  |  DSP  |  UniProtKB-KW
6898  |  TAT  |  UniProtKB-KW
3857  |  KRT9  |  UniProtKB-KW
10804  |  GJB6  |  UniProtKB-KW
9342  |  SNAP29  |  UniProtKB-KW
2707  |  GJB3  |  UniProtKB-KW
3853  |  KRT6A  |  UniProtKB-KW
3854  |  KRT6B  |  UniProtKB-KW
286887  |  KRT6C  |  UniProtKB-KW
80326  |  WNT10A  |  UniProtKB-KW
3872  |  KRT17  |  UniProtKB-KW
4014  |  LOR  |  UniProtKB-KW
1828  |  DSG1  |  UniProtKB-KW
1075  |  CTSC  |  UniProtKB-KW
51360  |  MBTPS2  |  UniProtKB-KW
162514  |  TRPV3  |  UniProtKB-KW
127534  |  GJB4  |  UniProtKB-KW
79651  |  RHBDF2  |  UniProtKB-KW
57152  |  SLURP1  |  CTD_human;UniProtKB-KW
8710  |  SERPINB7  |  UniProtKB-KW
3861  |  KRT14  |  UniProtKB-KW
79719  |  AAGAB  |  CTD_human;UniProtKB-KW
25959  |  KANK2  |  UniProtKB-KW
Inferring Gene(Waiting for update.)
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:74)
224  |  ALDH3A2  |  1.147  |  DISEASES
247  |  ALOX15B  |  1.46  |  DISEASES
1174  |  AP1S1  |  2.259  |  DISEASES
488  |  ATP2A2  |  2.951  |  DISEASES
820  |  CAMP  |  1.475  |  DISEASES
79092  |  CARD14  |  1.58  |  DISEASES
64170  |  CARD9  |  1.3  |  DISEASES
6349  |  CCL3L1  |  1.781  |  DISEASES
1137  |  CHRNA4  |  1.426  |  DISEASES
1650  |  DDOST  |  1.689  |  DISEASES
8632  |  DNAH17  |  3.348  |  DISEASES
81704  |  DOCK8  |  1.214  |  DISEASES
1825  |  DSC3  |  2.899  |  DISEASES
147409  |  DSG4  |  2.364  |  DISEASES
1832  |  DSP  |  5.579  |  DISEASES
2312  |  FLG  |  2.502  |  DISEASES
2316  |  FLNA  |  1.464  |  DISEASES
8811  |  GALR2  |  1.446  |  DISEASES
2701  |  GJA4  |  1.14  |  DISEASES
2706  |  GJB2  |  5.366  |  DISEASES
2707  |  GJB3  |  4.856  |  DISEASES
127534  |  GJB4  |  4.2  |  DISEASES
349149  |  GJC3  |  2.251  |  DISEASES
80318  |  GKAP1  |  3.369  |  DISEASES
29841  |  GRHL1  |  2.126  |  DISEASES
9931  |  HELZ  |  2.113  |  DISEASES
283987  |  HID1  |  3.265  |  DISEASES
9953  |  HS3ST3B1  |  2.608  |  DISEASES
3713  |  IVL  |  2.39  |  DISEASES
57158  |  JPH2  |  1.302  |  DISEASES
25959  |  KANK2  |  3.033  |  DISEASES
9314  |  KLF4  |  1.081  |  DISEASES
5650  |  KLK7  |  1.081  |  DISEASES
11202  |  KLK8  |  1.18  |  DISEASES
3853  |  KRT6A  |  5.491  |  DISEASES
5641  |  LGMN  |  1.318  |  DISEASES
59352  |  LGR6  |  2.183  |  DISEASES
4014  |  LOR  |  4.943  |  DISEASES
10161  |  LPAR6  |  1.944  |  DISEASES
4047  |  LSS  |  1.351  |  DISEASES
66004  |  LYNX1  |  3.894  |  DISEASES
137797  |  LYPD2  |  3.541  |  DISEASES
284348  |  LYPD5  |  4.099  |  DISEASES
7867  |  MAPKAPK3  |  1.912  |  DISEASES
51360  |  MBTPS2  |  2.914  |  DISEASES
26151  |  NAT9  |  2.229  |  DISEASES
4799  |  NFX1  |  2.623  |  DISEASES
123606  |  NIPA1  |  1.539  |  DISEASES
58484  |  NLRC4  |  1.744  |  DISEASES
4886  |  NPY1R  |  1.151  |  DISEASES
4889  |  NPY5R  |  1.812  |  DISEASES
5125  |  PCSK5  |  1.543  |  DISEASES
84720  |  PIGO  |  2.525  |  DISEASES
5329  |  PLAUR  |  3.862  |  DISEASES
5333  |  PLCD1  |  2.858  |  DISEASES
5339  |  PLEC  |  1.663  |  DISEASES
285848  |  PNPLA1  |  2.226  |  DISEASES
51371  |  POMP  |  2.752  |  DISEASES
8559  |  PRPF18  |  3.075  |  DISEASES
5916  |  RARG  |  1.433  |  DISEASES
79651  |  RHBDF2  |  5.278  |  DISEASES
284654  |  RSPO1  |  2.357  |  DISEASES
23328  |  SASH1  |  1.941  |  DISEASES
6303  |  SAT1  |  3.34  |  DISEASES
6397  |  SEC14L1  |  2.703  |  DISEASES
8710  |  SERPINB7  |  5.638  |  DISEASES
23451  |  SF3B1  |  2.006  |  DISEASES
8036  |  SHOC2  |  1.451  |  DISEASES
11005  |  SPINK5  |  2.365  |  DISEASES
6898  |  TAT  |  3.514  |  DISEASES
7124  |  TNF  |  1.155  |  DISEASES
162514  |  TRPV3  |  4.26  |  DISEASES
7390  |  UROS  |  1.044  |  DISEASES
26276  |  VPS33B  |  1.773  |  DISEASES
Locus(Waiting for update.)
Disease ID 1364
Disease palmoplantar keratosis
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:21)
HP:0000365  |  Hearing impairment  |  5
HP:0010783  |  Erythema  |  3
HP:0002224  |  Woolly hair  |  2
HP:0012245  |  Sex reversal  |  2
HP:0001638  |  Cardiomyopathy  |  2
HP:0000704  |  Pyorrhea  |  2
HP:0007410  |  Excessive sweating of palms and soles  |  1
HP:0000230  |  Inflamed gums  |  1
HP:0000613  |  Extreme light sensitivity  |  1
HP:0008064  |  Ichthyosis  |  1
HP:0008066  |  Skin bullae  |  1
HP:0012531  |  Pain  |  1
HP:0000164  |  Abnormality of the teeth  |  1
HP:0000407  |  sensorineural hearing loss  |  1
HP:0000975  |  Increased sweating  |  1
HP:0006480  |  Premature loss of teeth  |  1
HP:0001019  |  Exfoliative dermititis  |  1
HP:0200037  |  Skin vesicle  |  1
HP:0000824  |  Growth hormone deficiency  |  1
HP:0007475  |  Epidermolytic hyperkeratosis  |  1
HP:0000962  |  Hyperkeratosis  |  1
Disease ID 1364
Disease palmoplantar keratosis
Manually Symptom(Waiting for update.)
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:1)
C0878544  |  cardiomyopathy  |  2
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
Text Mining Genotype(Total Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:37)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs104894401200963562706GJB2umls:C0022596BeFreeHeLa cells stably expressing nine dominant Cx26 mutants, six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q and R75W), individually or together with Cx30, were analyzed by immunocytochemistry, co-immunoprecipitation, and functional assays (scrape-loading and/or fluorescence recovery after photobleaching).0.1327016862010GJB21320189154CT
rs1048944012009635610804GJB6umls:C0022596BeFreeHeLa cells stably expressing nine dominant Cx26 mutants, six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q and R75W), individually or together with Cx30, were analyzed by immunocytochemistry, co-immunoprecipitation, and functional assays (scrape-loading and/or fluorescence recovery after photobleaching).0.0005428842010GJB21320189154CT
rs104894401210407872706GJB2umls:C0022596BeFreeHeLa cells stably expressing wild type Cx26 were transiently transfected to co-express nine individual dominant Cx26 mutants; six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q, and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q, and R75W).0.1327016862011GJB21320189154CT
rs1048944022009635610804GJB6umls:C0022596BeFreeHeLa cells stably expressing nine dominant Cx26 mutants, six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q and R75W), individually or together with Cx30, were analyzed by immunocytochemistry, co-immunoprecipitation, and functional assays (scrape-loading and/or fluorescence recovery after photobleaching).0.0005428842010GJB21320189359GA
rs104894402210407872706GJB2umls:C0022596BeFreeHeLa cells stably expressing wild type Cx26 were transiently transfected to co-express nine individual dominant Cx26 mutants; six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q, and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q, and R75W).0.1327016862011GJB21320189359GA
rs104894402205831762706GJB2umls:C0022596BeFreeAutosomal dominant prelingual hearing loss with palmoplantar keratoderma syndrome: Variability in clinical expression from mutations of R75W and R75Q in the GJB2 gene.0.1327016862010GJB21320189359GA
rs104894402200963562706GJB2umls:C0022596BeFreeHeLa cells stably expressing nine dominant Cx26 mutants, six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q and R75W), individually or together with Cx30, were analyzed by immunocytochemistry, co-immunoprecipitation, and functional assays (scrape-loading and/or fluorescence recovery after photobleaching).0.1327016862010GJB21320189359GA
rs1048944042009635610804GJB6umls:C0022596BeFreeHeLa cells stably expressing nine dominant Cx26 mutants, six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q and R75W), individually or together with Cx30, were analyzed by immunocytochemistry, co-immunoprecipitation, and functional assays (scrape-loading and/or fluorescence recovery after photobleaching).0.0005428842010GJB21320189406CT,G
rs104894404200963562706GJB2umls:C0022596BeFreeHeLa cells stably expressing nine dominant Cx26 mutants, six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q and R75W), individually or together with Cx30, were analyzed by immunocytochemistry, co-immunoprecipitation, and functional assays (scrape-loading and/or fluorescence recovery after photobleaching).0.1327016862010GJB21320189406CT,G
rs104894404210407872706GJB2umls:C0022596BeFreeHeLa cells stably expressing wild type Cx26 were transiently transfected to co-express nine individual dominant Cx26 mutants; six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q, and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q, and R75W).0.1327016862011GJB21320189406CT,G
rs104894406210407872706GJB2umls:C0022596BeFreeHeLa cells stably expressing wild type Cx26 were transiently transfected to co-express nine individual dominant Cx26 mutants; six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q, and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q, and R75W).0.1327016862011GJB21320188977CA
rs104894406200963562706GJB2umls:C0022596BeFreeHeLa cells stably expressing nine dominant Cx26 mutants, six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q and R75W), individually or together with Cx30, were analyzed by immunocytochemistry, co-immunoprecipitation, and functional assays (scrape-loading and/or fluorescence recovery after photobleaching).0.1327016862010GJB21320188977CA
rs1048944062009635610804GJB6umls:C0022596BeFreeHeLa cells stably expressing nine dominant Cx26 mutants, six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q and R75W), individually or together with Cx30, were analyzed by immunocytochemistry, co-immunoprecipitation, and functional assays (scrape-loading and/or fluorescence recovery after photobleaching).0.0005428842010GJB21320188977CA
rs104894407210407872706GJB2umls:C0022596BeFreeHeLa cells stably expressing wild type Cx26 were transiently transfected to co-express nine individual dominant Cx26 mutants; six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q, and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q, and R75W).0.1327016862011GJB21320189450CT,G
rs104894407200963562706GJB2umls:C0022596BeFreeHeLa cells stably expressing nine dominant Cx26 mutants, six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q and R75W), individually or together with Cx30, were analyzed by immunocytochemistry, co-immunoprecipitation, and functional assays (scrape-loading and/or fluorescence recovery after photobleaching).0.1327016862010GJB21320189450CT,G
rs1048944072009635610804GJB6umls:C0022596BeFreeHeLa cells stably expressing nine dominant Cx26 mutants, six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q and R75W), individually or together with Cx30, were analyzed by immunocytochemistry, co-immunoprecipitation, and functional assays (scrape-loading and/or fluorescence recovery after photobleaching).0.0005428842010GJB21320189450CT,G
rs1048944132009635610804GJB6umls:C0022596BeFreeHeLa cells stably expressing nine dominant Cx26 mutants, six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q and R75W), individually or together with Cx30, were analyzed by immunocytochemistry, co-immunoprecipitation, and functional assays (scrape-loading and/or fluorescence recovery after photobleaching).0.0005428842010GJB21320189451CT,G
rs104894413210407872706GJB2umls:C0022596BeFreeHeLa cells stably expressing wild type Cx26 were transiently transfected to co-express nine individual dominant Cx26 mutants; six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q, and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q, and R75W).0.1327016862011GJB21320189451CT,G
rs104894413200963562706GJB2umls:C0022596BeFreeHeLa cells stably expressing nine dominant Cx26 mutants, six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q and R75W), individually or together with Cx30, were analyzed by immunocytochemistry, co-immunoprecipitation, and functional assays (scrape-loading and/or fluorescence recovery after photobleaching).0.1327016862010GJB21320189451CT,G
rs201783640200963562706GJB2umls:C0022596BeFreeHeLa cells stably expressing nine dominant Cx26 mutants, six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q and R75W), individually or together with Cx30, were analyzed by immunocytochemistry, co-immunoprecipitation, and functional assays (scrape-loading and/or fluorescence recovery after photobleaching).0.1327016862010GJB61320223053CT
rs2017836402009635610804GJB6umls:C0022596BeFreeHeLa cells stably expressing nine dominant Cx26 mutants, six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q and R75W), individually or together with Cx30, were analyzed by immunocytochemistry, co-immunoprecipitation, and functional assays (scrape-loading and/or fluorescence recovery after photobleaching).0.0005428842010GJB61320223053CT
rs28931593205831762706GJB2umls:C0022596BeFreeAutosomal dominant prelingual hearing loss with palmoplantar keratoderma syndrome: Variability in clinical expression from mutations of R75W and R75Q in the GJB2 gene.0.1327016862010GJB21320189358CT
rs28931593200963562706GJB2umls:C0022596BeFreeHeLa cells stably expressing nine dominant Cx26 mutants, six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q and R75W), individually or together with Cx30, were analyzed by immunocytochemistry, co-immunoprecipitation, and functional assays (scrape-loading and/or fluorescence recovery after photobleaching).0.1327016862010GJB21320189358CT
rs28931593210407872706GJB2umls:C0022596BeFreeHeLa cells stably expressing wild type Cx26 were transiently transfected to co-express nine individual dominant Cx26 mutants; six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q, and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q, and R75W).0.1327016862011GJB21320189358CT
rs28931593123720582706GJB2umls:C0022596BeFreeThe novel R75Q mutation in the GJB2 gene causes autosomal dominant hearing loss and palmoplantar keratoderma in a Turkish family.0.1327016862002GJB21320189358CT
rs289315932009635610804GJB6umls:C0022596BeFreeHeLa cells stably expressing nine dominant Cx26 mutants, six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q and R75W), individually or together with Cx30, were analyzed by immunocytochemistry, co-immunoprecipitation, and functional assays (scrape-loading and/or fluorescence recovery after photobleaching).0.0005428842010GJB21320189358CT
rs28931593249754032706GJB2umls:C0022596BeFreeR75Q de novo dominant mutation of GJB2 in a Chinese family with hearing loss and palmoplantar keratoderma.0.1327016862014GJB21320189358CT
rs28931595200963562706GJB2umls:C0022596BeFreeHeLa cells stably expressing nine dominant Cx26 mutants, six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q and R75W), individually or together with Cx30, were analyzed by immunocytochemistry, co-immunoprecipitation, and functional assays (scrape-loading and/or fluorescence recovery after photobleaching).0.1327016862010GJB21320189047CT,A
rs28931595210407872706GJB2umls:C0022596BeFreeHeLa cells stably expressing wild type Cx26 were transiently transfected to co-express nine individual dominant Cx26 mutants; six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q, and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q, and R75W).0.1327016862011GJB21320189047CT,A
rs289315952009635610804GJB6umls:C0022596BeFreeHeLa cells stably expressing nine dominant Cx26 mutants, six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q and R75W), individually or together with Cx30, were analyzed by immunocytochemistry, co-immunoprecipitation, and functional assays (scrape-loading and/or fluorescence recovery after photobleaching).0.0005428842010GJB21320189047CT,A
rs57499817164172213852KRT5umls:C0022596BeFreeInstead, they have been associated with several distinct clinical phenotypes, such as epidermolysis bullosa simplex with mottled pigmentation (mutation P25L in the V1 domain of keratin 5), epidermolysis bullosa simplex with migratory circinate erythema (frameshift mutation c1649delG in the V2 domain of keratin 5), striate palmoplantar keratoderma (PPK), and ichthyosis hystrix Curth-Macklin (different frameshift mutations in the V2 domain of keratin 1 (K1)).0.0002714422006KRT51252520223GA
rs57499817164172213848KRT1umls:C0022596BeFreeInstead, they have been associated with several distinct clinical phenotypes, such as epidermolysis bullosa simplex with mottled pigmentation (mutation P25L in the V1 domain of keratin 5), epidermolysis bullosa simplex with migratory circinate erythema (frameshift mutation c1649delG in the V2 domain of keratin 5), striate palmoplantar keratoderma (PPK), and ichthyosis hystrix Curth-Macklin (different frameshift mutations in the V2 domain of keratin 1 (K1)).0.0032573022006KRT51252520223GA
rs59616921191060413857KRT9umls:C0022596BeFreeKnuckle pads, in an epidermal palmoplantar keratoderma patient with Keratin 9 R163W transgrediens expression.0.0141547032009KRT91741571506GA
rs59616921105369903857KRT9umls:C0022596BeFreeR162W mutation of keratin 9 in a family with autosomal dominant palmoplantar keratoderma with unique histologic features.0.0141547031999KRT91741571506GA
rs80338950210407872706GJB2umls:C0022596BeFreeHeLa cells stably expressing wild type Cx26 were transiently transfected to co-express nine individual dominant Cx26 mutants; six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q, and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q, and R75W).0.1327016862011GJB21320189031CT,G
rs803389502009635610804GJB6umls:C0022596BeFreeHeLa cells stably expressing nine dominant Cx26 mutants, six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q and R75W), individually or together with Cx30, were analyzed by immunocytochemistry, co-immunoprecipitation, and functional assays (scrape-loading and/or fluorescence recovery after photobleaching).0.0005428842010GJB21320189031CT,G
rs80338950200963562706GJB2umls:C0022596BeFreeHeLa cells stably expressing nine dominant Cx26 mutants, six associated with non-syndromic hearing loss (W44C, W44S, R143Q, D179N, R184Q and C202F) and three associated with hearing loss and palmoplantar keratoderma (G59A, R75Q and R75W), individually or together with Cx30, were analyzed by immunocytochemistry, co-immunoprecipitation, and functional assays (scrape-loading and/or fluorescence recovery after photobleaching).0.1327016862010GJB21320189031CT,G
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Disease ID 1364
Disease palmoplantar keratosis
Case(Waiting for update.)